Trait centric view

1. Trait name:	Drip loss
   Ontology terms:	LPT:1000619

   43 genes are associated with this trait, with QTL/association found

   • ABCA4: ATP binding cassette subfamily A member 4
     evidenced by: QTL:264190;
   • ANK1: Ankyrin 1, erythrocytic
     evidenced by: QTL:12072;
   • AVPR1B: Arginine vasopressin receptor 1B
     evidenced by: QTL:24232;
   • BVES: Blood vessel epicardial substance
     evidenced by: QTL:17825;
   • CAST: Calpastatin
     evidenced by: QTL:17497; QTL:17499; QTL:17501; QTL:17503; QTL:17504; QTL:17506; QTL:17507; QTL:17509; QTL:17510; QTL:17512; QTL:17513; QTL:17514; QTL:17516; QTL:17517; QTL:17518; QTL:17519; QTL:17521; QTL:17523;
   • CDYL2: Chromodomain Y like 2
     evidenced by: QTL:264195;
   • CFAP77: Cilia and flagella associated protein 77
     evidenced by: QTL:264179;
   • CHL1: Cell adhesion molecule L1 like
     evidenced by: QTL:264219; QTL:264220;
   • CS: Citrate synthase
     evidenced by: QTL:17830;
   • DGAT: Diacylglycerol acyltransferase
     evidenced by: QTL:28199;
   • DIO3: Deiodinase, iodothyronine, type III
     evidenced by: QTL:17885;
   • EDN3: Endothelin 3
     evidenced by: QTL:125806;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:264196; QTL:264197;
   • FABP3: Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
     evidenced by: QTL:17343;
   • FAM110B: Family with sequence similarity 110, member B
     evidenced by: QTL:21948;
   • FASN: Fatty acid synthase
     evidenced by: QTL:193123;
   • HCAR1: Hydroxycarboxylic acid receptor 1
     evidenced by: QTL:264222;
   • HSD17B4: Hydroxysteroid 17-beta dehydrogenase 4
     evidenced by: QTL:122478;
   • IL1B: Interleukin 1, beta
     evidenced by: QTL:373;
   • ITGA4: Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
     evidenced by: QTL:21951;
   • KDM2A: Lysine (K)-specific demethylase 2A
     evidenced by: QTL:17585;
   • LDHA: Lactate dehydrogenase A
     evidenced by: QTL:9822;
   • LYZ: Lysozyme
     evidenced by: QTL:9847;
   • MIR206: MicroRNA mir-206
     evidenced by: QTL:66004;
   • MIR208B: MicroRNA mir-208b
     evidenced by: QTL:36304;
   • MYOD1: Myogenic differentiation 1
     evidenced by: QTL:23123; QTL:23150;
   • NR3C1: Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
     evidenced by: QTL:24235; QTL:25305;
   • PDZRN4: PDZ domain containing ring finger 4
     evidenced by: QTL:264192;
   • PHACTR3: Phosphatase and actin regulator 3
     evidenced by: QTL:125809;
   • PHKG: Phosphorylase kinase gamma subunit
     evidenced by: QTL:37554;
   • PITX2: Paired-like homeodomain 2
     evidenced by: QTL:17863; QTL:17866;
   • PKM: Pyruvate kinase, muscle
     evidenced by: QTL:13464; QTL:13465; QTL:13472;
   • PRKAG3: Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
     evidenced by: QTL:179188; QTL:179192; QTL:179198; QTL:179206; QTL:23996; QTL:23997; QTL:23999; QTL:24003; QTL:24007; QTL:24011; QTL:24016; QTL:24019;
   • SERPINA6: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
     evidenced by: QTL:7659;
   • SERPING1: Serpin family G member 1
     evidenced by: QTL:135453;
   • SIL1: SIL1 nucleotide exchange factor
     evidenced by: QTL:264182;
   • SLC15A4: Solute carrier family 15 member 4
     evidenced by: QTL:138394; QTL:138397;
   • SLC1A2: Solute carrier family 1 member 2
     evidenced by: QTL:264180; QTL:264181;
   • SLC25A17: Solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17
     evidenced by: QTL:21949;
   • STAR: Steroidogenic acute regulatory protein
     evidenced by: QTL:24233;
   • UPF2: UPF2 regulator of nonsense mediated mRNA decay
     evidenced by: QTL:264214; QTL:264215;
   • VTN: Vitronectin
     evidenced by: QTL:9846;
   • ZDHHC5: Zinc finger, DHHC-type containing 5
     evidenced by: QTL:17829;
   208 correlations are found involving Drip loss